Reproductive Cancer and its Impact on African American Women

Gynecologic Cancer poses a serious health threat for all women. However, for African American women in particular, disproportionate numbers are still shouldering a heavier burden of premature mortality as evidenced by the following surveillance data:

  • Although cervical cancer incidence is the highest among Latina women, African American women have lower 5-year survival rates and die from the disease more than any other race (Black Women’s Health Imperative, formerly the National Black Women’s Health Project).
  • African American women observe a lower incidence rate of endometrial cancer as compared to Caucasian women, but die from the disease at almost twice the rate as Caucasian women (Surveillance, Epidemiology and End Results (SEER) Program and the National Center for Health Statistics).
  • Ovarian cancer is recognized as the most lethal type of reproductive cancer, claiming more than 15,000 lives annually. Although African American women are diagnosed less frequently than their Caucasian counterparts, 5-year survival rates are much lower. To date, very little research has been conducted on ovarian cancer in African American women. Mysteries still confound the medical community, patients, survivors and the larger community (UIC Institute for Health Research and Policy).

These realities underscore the importance of wide scale public awareness campaigns targeting the African American community with important messages about steps that can and must be taken to reverse these disparities in order to promote prevention, early detection and optimal treatment.

The Foundation for Women’s Cancer wants all women to LEARN the symptoms, LISTEN to their bodies, and ACT by seeking care from a gynecologic oncologist for the best outcomes, if they suspect or have been diagnosed with a reproductive cancer.

Learn more about the LEARN-LISTEN-ACT campaign and how it pertains to your specific type of gynecologic cancer.

Spotlight

Hear from Dr. Anil Sood, the Foundation’s Research Chairman, and Carol Brown, 2014 SGO Program Chair, about research of interest to women and the public presented at the 2014 SGO Annual Meeting on Women’s Cancer. Watch the video

Awareness

A new SGO Clinical Practice Statement states women diagnosed with epithelial ovarian, tubal, and peritoneal cancers should be considered for genetic counseling and testing, even in the absence of a family history.

Education

The next Gynecologic Cancer Survivors Course Friday, May 2, 2014 in Long Island, NY. For more information on courses, click here.